Polymyositis: Difference between revisions
(14 intermediate revisions by 6 users not shown) | |||
Line 3: | Line 3: | ||
==Clinical Features== | ==Clinical Features== | ||
* Symmetrical proximal muscle weakness with insidious onset | *Symmetrical proximal muscle weakness with insidious onset | ||
* Generally painless (though 30% have myalgia) | *Generally painless (though 30% have myalgia) | ||
* Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position | *Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position | ||
* Weak neck extensors causing difficulty of holding head up | *Weak neck extensors causing difficulty of holding head up | ||
* Associated arthralgias | *Associated arthralgias | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Myalgia DDX}} | |||
{{Weakness DDX}} | {{Weakness DDX}} | ||
== | ==Evaluation== | ||
* CBC | *CBC | ||
*ESR | |||
*CRP | |||
*CK | |||
*[[Urinalysis]] | |||
*Consider: | |||
**RF | |||
**ANA | |||
**Anti-Jo-1 | |||
==Management== | ==Management== | ||
* Prednisone 1mg/kg/day for 4-8 weeks until CK returns to reference range | *[[Prednisone]] 1mg/kg/day for 4-8 weeks until CK returns to reference range | ||
* Followed by prednisone taper | **Followed by [[prednisone]] taper | ||
* Methotrexate as second line for poor response to corticosteroids | *Other treatments that rheum may prescribe: | ||
* Other agents with less evidence: IVIG, TNF Inhibitors | **[[Methotrexate]] as second line for poor response to corticosteroids | ||
**Other agents with less evidence: IVIG, TNF Inhibitors | |||
==Disposition== | ==Disposition== | ||
* Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms | *Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms | ||
*Very strongly associated with malignancy (~30%), especially:<ref>Hill CL et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001 Jan 13;357(9250):96-100.</ref> | |||
**Ovarian | |||
**Lung | |||
**Pancreatic | |||
**Stomach | |||
**Colorectal | |||
**Lymphoma | |||
**Bladder | |||
==See Also== | |||
*[[Weakness]] | |||
==References== | ==References== | ||
<references/> | |||
[[Category: | [[Category:Rheumatology]] | ||
[[Category: | [[Category:Neurology]] |
Revision as of 00:59, 2 April 2019
Background
Idiopathic inflammatory myopathy causing symmetric proximal muscle weakness, elevated CK,and characteristic EMG findings
Clinical Features
- Symmetrical proximal muscle weakness with insidious onset
- Generally painless (though 30% have myalgia)
- Difficulty with kneeling, climbing stairs, combing hair, or rising from a seated position
- Weak neck extensors causing difficulty of holding head up
- Associated arthralgias
Differential Diagnosis
Myalgia
- Infection:
- Viral infection (e.g. Influenza)
- Bacterial infection
- Spirochete infection (E.g. Dengue fever; Trichinella)
- Drugs:
- Statins
- Bisphosphonates
- Corticosteroids
- Ciprofloxacin
- Clofibrate
- Colchicine
- Chloroquine
- Emetine
- Aminocaproic acid
- Zidovudine
- Bretylium
- Penicillamine
- Drugs causing hypokalemia
- Metabolic disorders:
- Vitamin D deficiency
- Mitochondrial myopathy
- Scurvy
- Osteomalacia
- Fibromyalgia
- Endocrine:
- Polymyalgia rheumatica
- Rhabdomyolysis
- Myositis
- Systemic lupus erythematosus
- Rheumatoid arthritis
- Inclusion body myositis
- Sarcoidosis
- Scleroderma
- Sjögren’s syndrome
- Psychiatric (e.g. somatic manifestations of depression)
- Domestic abuse
- Crush injury
- Lyme disease
- Ehlers-Danlos syndrome(hypermobility syndrome)
- HIV myopathy
- Hypophosphatemia
- Hypokalemia
- Hypothermia
- Prolonged immobility
- Strenuous exercise (overuse) or heat stroke
- Seizure
- Severe volume contraction
- Alcoholism
- Muscular dystrophy
- Duchenne
- Becker
- Limb-girdle
- Facioscapulohumeral
- Myotonic dystrophy
- Myotonia congenita
- Compartment syndrome; Muscle infarction
- Neuropathic
- Chronic fatigue syndrome
- Vasculitis
- Sarcocystosis
- Spinal stenosis
- Diabetic lumbosacral plexopathy
Weakness
- Neuromuscular weakness
- Upper motor neuron:
- CVA
- Hemorrhagic stroke
- Multiple sclerosis
- Amyotrophic Lateral Sclerosis (ALS) (upper and lower motor neuron)
- Lower motor neuron:
- Spinal and bulbar muscular atrophy (Kennedy's syndrome)
- Spinal cord disease:
- Infection (Epidural abscess)
- Infarction/ischemia
- Trauma (Spinal Cord Syndromes)
- Inflammation (Transverse Myelitis)
- Degenerative (Spinal muscular atrophy)
- Tumor
- Peripheral nerve disease:
- Neuromuscular junction disease:
- Muscle disease:
- Rhabdomyolysis
- Dermatomyositis
- Polymyositis
- Alcoholic myopathy
- Upper motor neuron:
- Non-neuromuscular weakness
- Can't miss diagnoses:
- ACS
- Arrhythmia/Syncope
- Severe infection/Sepsis
- Hypoglycemia
- Periodic paralysis (electrolyte disturbance, K, Mg, Ca)
- Respiratory failure
- Emergent Diagnoses:
- Symptomatic Anemia
- Severe dehydration
- Hypothyroidism
- Polypharmacy
- Malignancy
- Aortic disease - occlusion, stenosis, dissection
- Other causes of weakness and paralysis
- Acute intermittent porphyria (ascending weakness)
- Can't miss diagnoses:
Evaluation
- CBC
- ESR
- CRP
- CK
- Urinalysis
- Consider:
- RF
- ANA
- Anti-Jo-1
Management
- Prednisone 1mg/kg/day for 4-8 weeks until CK returns to reference range
- Followed by prednisone taper
- Other treatments that rheum may prescribe:
- Methotrexate as second line for poor response to corticosteroids
- Other agents with less evidence: IVIG, TNF Inhibitors
Disposition
- Rheumatology or neurology consultation either in ED or as outpatient depending on severity of symptoms
- Very strongly associated with malignancy (~30%), especially:[1]
- Ovarian
- Lung
- Pancreatic
- Stomach
- Colorectal
- Lymphoma
- Bladder
See Also
References
- ↑ Hill CL et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet. 2001 Jan 13;357(9250):96-100.